Homocysteine-lowering interventions in chronic kidney disease

• मुख्य लेखकों: Shirinsadat Badri (लेखक), Sahar Vahdat (लेखक), Shiva Seirafian (लेखक), Morteza Pourfarzam (लेखक), Tahereh Gholipur-Shahraki (लेखक), Sara Ataei (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The incidence of cardiovascular events and mortality is higher in patients with chronic kidney disease (CKD) compared to the general population. Homocysteine (Hcy) appears to be an independent risk factor for cardiovascular diseases in general populations and patients with CKD. Further, hyperhomocys...